Activated dynamics plays a central role in protein function, where transitions between distinct conformations often underlie the switching between active and inactive states. The characteristic time scales of these transitions typically fall in the microsecond to millisecond range, which is amenable to investigations by NMR relaxation dispersion experiments. Processes at the faster end of this range are more challenging to study, because higher RF field strengths are required to achieve refocusing of the exchanging magnetization. Here we describe a rotating-frame relaxation dispersion experiment for (1)H spins in methyl (13)CHD2 groups, which improves the characterization of fast exchange processes. The influence of (1)H-(1)H rotating-frame nuclear Overhauser effects (ROE) is shown to be negligible, based on a comparison of R 1ρ relaxation data acquired with tilt angles of 90° and 35°, in which the ROE is maximal and minimal, respectively, and on samples containing different (1)H densities surrounding the monitored methyl groups. The method was applied to ubiquitin and the apo form of calmodulin. We find that ubiquitin does not exhibit any (1)H relaxation dispersion of its methyl groups at 10 or 25 °C. By contrast, calmodulin shows significant conformational exchange of the methionine methyl groups in its C-terminal domain, as previously demonstrated by (1)H and (13)C CPMG experiments. The present R 1ρ experiment extends the relaxation dispersion profile towards higher refocusing frequencies, which improves the definition of the exchange correlation time, compared to previous results.
Thiopurine S-methyltransferase (TPMT) is a polymorphic enzyme involved in the metabolism and inactivation of thiopurine substances administered as immunosuppressants in the treatment of malignancies and autoimmune diseases. In this study, the naturally occurring variants, TPMT*6 (Y180F) and TPMT*8 (R215H), have been biophysically characterized. Despite being classified as low and intermediate in vivo enzyme activity variants, respectively, our results demonstrate a discrepancy because both TPMT*6 and TPMT*8 were found to exhibit normal functionality in vitro. While TPMT*8 exhibited biophysical properties almost indistinguishable from those of TPMTwt, the TPMT*6 variant was found to be destabilized. Furthermore, the contributions of the cofactor S-adenosylmethionine (SAM) to the thermodynamic stability of TPMT were investigated, but only a modest stabilizing effect was observed. Also presented herein is a new method for studies of the biophysical characteristics of TPMT and its variants using the extrinsic fluorescent probe 8-anilinonaphthalene-1-sulfonic acid (ANS). ANS was found to bind strongly to all investigated TPMT variants with a Kd of approximately 0.2 μM and a 1:1 binding ratio as determined by isothermal titration calorimetry (ITC). Circular dichroism and fluorescence measurements showed that ANS binds exclusively to the native state of TPMT, and binding to the active site was confirmed by molecular modeling and simulated docking as well as ITC measurements. The strong binding of the probe to native TPMT and the conformity of the obtained results demonstrate the advantages of using ANS binding characteristics in studies of this protein and its variants.
A major drawback of nuclear magnetic resonance (NMR) spectroscopy compared to other methods is that the technique has been limited to relatively small molecules. However, in the last two decades the size limit has been pushed upwards considerably and it is now possible to use NMR spectroscopy for structure calculations of proteins of molecular weights approaching 100 kDa and to probe dynamics for supramolecular complexes of molecular weights in excess of 500 kDa. Instrumental for this progress has been development in instrumentation and pulse sequence design but also improved isotopic labeling schemes that lead to increased sensitivity as well as improved spectral resolution and simplification. These are described and discussed in this chapter, focusing on labeling schemes for amide proton and methyl proton detected experiments. We also discuss labeling methods for other potentially useful positions in proteins.
Nuclear magnetic spin relaxation has emerged as a powerful technique for probing molecular dynamics. Not only is it possible to use it for determination of time constant(s) for molecular reorientation but it can also be used to characterize internal motions on time scales from picoseconds to seconds. Traditionally, uniformly (15)N labeled samples have been used for these experiments but it is clear that this limits the applications. For instance, sensitivity for large systems is dramatically increased if dynamics is probed at methyl groups and structural characterization of low-populated states requires measurements on (13)Cα, (13)Cβ or (13)CO or (1)Hα. Unfortunately, homonuclear scalar couplings may lead to artifacts in the latter types of experiments and selective isotopic labeling schemes that only label the desired position are necessary. Both selective and uniform labeling schemes for measurements of relaxation rates for a large number of positions in proteins are discussed in this chapter.
Populärvetenskaplig sammanfattningProteinet TPMT och tiopurinläkemedel I kroppens celler finns proteinet tiopurinmetyltransferas, vilket vanligtvis förkortas TPMT. Trots att det är vanligt förekommande är proteinets naturliga funktion fortfarande okänd. Vi vet dock att TPMT inaktiverar en viss typ av läkemedel som kallas tiopuriner, därav proteinets namn. Tiopuriner är en typ av cytostatika (cellgifter) som använd vid behandling av sjukdomstillstånd relaterade till ett överaktivt immunförsvar och vissa former av leukemi. Tiopurinläkemedel är förstklassiga imitatörer; de efterliknar nämligen byggstenarna till vårt DNA. Cellen kan inte skilja imitatör från original utan bygger in tiopurinerna i nytt DNA. DNA som innehåller tiopuriner är odugligt, vilket gör att cellen till slut dör. Eftersom cellen kopierar sitt DNA före delning så kommer tiopurinläkemedel i större utsträckning påverka celler som delar sig ofta, och man får därmed en riktad effekt mot överaktiva immunceller och cancerceller. TPMT komplicerar läkemedelsbehandlingProteinet TPMT inaktiverar tiopurinläkemedel, och det får tyvärr konsekvenser för patienter som behandlas med dessa substanser. Inaktiveringen sker genom att proteinet modifierar tiopurinerna genom så kallad metylering. De modifierade läkemedelsmolekylerna liknar inte längre de naturliga DNA-baserna, och läkemedlets celldödande effekt minskar därmed. För att kompensera för TPMTs härjningar måste läkemedelsdosen höjas så att tillräcklig effekt uppnås. Dock finns det flertalet naturligt förekommande varianter av proteinet, vilket ytterligare komplicerar behandlingen. Att det finns olika varianter av ett protein är en naturlig i del av den genetiska variationen i en population, men alla TPMTvarianterna inte är lika benägna att inaktivera tiopurinläkemedel. Vissa varianter är ambitiösa och inaktiverar en större mängd tiopurinerde är alltså högaktiva. Andra är betydligt sämre på att inaktivera läkemedelsmolekyler -de är med andra ord lågaktiva. En konsekvens av varianternas olika egenskaper är att det förekommer individuella skillnader i hur man reagerar på tiopurinläkemedel, beroende på vilken typ av TPMT-protein man har anlag för. Det gör doseringen av tiopuriner komplicerad. En patient som har gener för en lågaktiv TPMT-variant riskerar att överdoseras, vilket kan leda till att immunförsvaret slås ut helt. En patient som har högaktivt TPMT-protein bildar istället stora mängder inaktiverade läkemedelsmolekyler, vilka kan skada levern vid höga halter. För att göra behandling med tiopurinläkemedel säkrare görs rutinmässigt en kontroll av vilken typ av TPMT-protein patienten har, och därefter skräddarsys doseringen för varje patient. Man övervakar också patienten med regelbundna provtagningar för att kontrollera att mängden läkemedel är på rätt nivå. Biokemin som hjälpmedelI vår forskning studerar vi utvalda TPMT-varianter för att förklara vad som orsakar deras olika biofysikaliska egenskaper. Vi har bland annat kunnat visa att den molekylära strukturen hos en variant, TPMT*6 (Y180F), är lite min...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.